$4.41
-0.12-2.65%
At close: -
$4.51
0.12.26%
After Hours: Dec 20, 6:59 PM EDT
Comments
Loading...
Aptevo Therapeutics (APVO) Forecast
NewsEarningsAptevo Therapeutics (APVO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestAptevo Therapeutics (NASDAQ:APVO) Stock Quotes, Forecast and News Summary
Aptevo Therapeutics Stock (NASDAQ: APVO) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Aptevo Therapeutics (APVO) stock?
You can purchase shares of Aptevo Therapeutics (NASDAQ:APVO) through any online brokerage.
Who are Aptevo Therapeutics (APVO) competitors?
Other companies in Aptevo Therapeutics’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO), Bone Biologics (NASDAQ:BBLG) and Qualigen Therapeutics (NASDAQ:QLGN).
What is the forecast, or price target, for Aptevo Therapeutics (APVO) stock?
Aptevo Therapeutics has a consensus price target of $14.00.
What is the current price for Aptevo Therapeutics (APVO)?
The stock price for Aptevo Therapeutics (NASDAQ: APVO) is $4.5095 last updated December 20, 2024 at 6:59 PM EST.
Does Aptevo Therapeutics (APVO) pay a dividend?
There are no upcoming dividends for Aptevo Therapeutics.
When is Aptevo Therapeutics (NASDAQ:APVO) reporting earnings?
Aptevo Therapeutics’s Q4 earnings are confirmed for Tuesday, March 4, 2025.
Is Aptevo Therapeutics (APVO) going to split?
There is no upcoming split for Aptevo Therapeutics.
What sector and industry does Aptevo Therapeutics (APVO) operate in?
Aptevo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.